Glatiramer Acetate DEA Distribution Analysis

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

The existing methods for manufacturing glatiramer acetate (GA) lack detailed physicochemical characterization, particularly regarding diethylamide (DEA) distribution, which is crucial for ensuring compliance with industrial and regulatory standards and maintaining manufacturing consistency.

Innovation Solution

The proposed methods involve assessing and controlling the distribution of diethylamide-modified amino acids in GA and its polymeric precursors through specific ratios and levels, using techniques like chromatography and mass spectrometry to select and identify batches that meet predetermined reference values, ensuring consistency and quality.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If detailed physicochemical characterization of DEA distribution is implemented, then manufacturing precision and quality control are improved, but device complexity and analysis time increase

Engineering Contradiction:

ImproveDEA distribution controlVSAvoidanalysis methodology

Core Design Contradiction:

Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent segments the complex DEA distribution analysis into distinct measurable components: total DEA content, DEA-modified amino acid composition, and molecular weight distribution. This segmentation allows each parameter to be analyzed separately using appropriate analytical techniques, reducing the overall complexity while maintaining comprehensive characterization.

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The patent establishes predetermined reference ranges for DEA distribution parameters before manufacturing batches. By setting acceptance criteria in advance (e.g., DEA content ranges, amino acid composition ratios), the patent eliminates the need for complex real-time decision-making during quality assessment, streamlining the evaluation process.

Inventive Principle:

Principle #10Preliminary action

2Reliability

If comprehensive DEA distribution assessment is performed, then batch selection accuracy is improved, but measurement precision requirements and analysis time increase

Engineering Contradiction:

Improvebatch selectionVSAvoidDEA distribution measurement

Core Design Contradiction:

ReliabilityVSMeasurement precision

Solution Approach 1:

The patent implements a tiered assessment approach where essential DEA distribution parameters (total DEA content and major amino acid composition) are measured with high precision, while less critical parameters are assessed with moderate precision. This partial action approach achieves sufficient batch selection reliability without requiring excessive measurement precision across all parameters.

Inventive Principle:

Principle #16Partial or excessive action

Solution Approach 2:

The patent transforms the complex multi-dimensional DEA distribution data into simplified comparative parameters against reference ranges. By changing the representation from detailed compositional data to binary pass/fail assessments based on predetermined ranges, the patent reduces measurement precision requirements while maintaining reliable batch selection.

Inventive Principle:

Principle #35Parameter changes

3Stability of the object's composition

If strict DEA distribution criteria are enforced, then product quality consistency is improved, but manufacturing flexibility and batch acceptance rate decrease

Engineering Contradiction:

Improvebatch-to-batch consistencyVSAvoidmanufacturing flexibility

Core Design Contradiction:

Stability of the object's compositionVSAdaptability or versatility

Solution Approach 1:

The patent implements dynamic manufacturing flexibility by allowing deviation from target DEA distribution values within predetermined acceptable ranges. Rather than enforcing strict fixed targets, the patent uses ranges that can accommodate normal manufacturing variability, maintaining composition consistency while preserving manufacturing adaptability.

Inventive Principle:

Principle #15Dynamics

Solution Approach 2:

The patent applies different strictness levels to different DEA distribution parameters based on their impact on product quality. Critical parameters (e.g., total DEA content) have narrower acceptable ranges, while less critical parameters have broader ranges, allowing local quality control that maintains consistency where needed without unnecessarily restricting manufacturing flexibility.

Inventive Principle:

Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for precise assessment and selection of GA batches based on DEA distribution, ensuring compliance with standards and maintaining batch-to-batch consistency, thereby enhancing the quality control and manufacturing process of GA.

Implementation Method 1

using techniques like chromatography and mass spectrometry to select and identify batches that meet predetermined reference values

Methodology Applied

Scientific EffectChromatography: Chromatography

Implementation Method 2

using techniques like chromatography and mass spectrometry to select and identify batches that meet predetermined reference values

Methodology Applied

Scientific EffectMass spectrometry:

Data Source

PatentUS8765911B2Evaluation of copolymer diethylamide

Publication Date: 2014.07.01 MOMENTA PHARMACEUTICALS INC

AI summary

Methods of analyzing glatiramer acetate (GA) or a polymeric precursor thereof are provided. The methods can include determining a level of one or more diethylamide-modified amino acids in a sample comprising GA or a polymeric precursor thereof, and selecting at least a portion of the sample based on the assessment of the one or more diethylamide-modified amino acids in the sample.